StockDocs
Main Newswire Learn
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
OSIS

OSI Systems, Inc.

OSIS Nasdaq Semiconductors & Related Devices EDGAR ↗
$192.30
-0.74 -0.38%

Key statistics

from XBRL data in SEC filings
Market cap ⓘ
$3.07B
Revenue (TTM) ⓘ
$1.79B
Net income (TTM) ⓘ
$155M
EPS (TTM) ⓘ
$9.00
P/E ratio ⓘ
21.4
Dividend yield ⓘ
—
Free cash flow ⓘ
$245M
Cash ⓘ
$360M
Total assets ⓘ
$2.50B
Gross margin ⓘ
33.2%
52-week range ⓘ
$186.50 – $311.72

AI briefing

from the latest 10-K, 10-Q and 8-K events

OSI Systems is a vertically integrated designer and manufacturer of specialized electronic systems for security, healthcare, and defense/aerospace markets.

What they do

OSI Systems operates through three divisions: Security (security screening and high-power RF systems), Optoelectronics and Manufacturing (specialized electronic components and manufacturing services), and Healthcare (patient monitoring and connected care). The company sells globally, with a large percentage of revenue generated outside the United States.

Revenue drivers

  • Security Division — Provides security screening products, turnkey screening solutions, and high-power RF systems; accounted for 70% of fiscal 2026 consolidated revenues.
  • Optoelectronics and Manufacturing Division — Designs and manufactures optoelectronic devices and provides electronics manufacturing services; accounted for 21% of fiscal 2026 revenues.
  • Healthcare Division — Patient monitoring, cardiology, and connected care systems; accounted for 9% of fiscal 2026 revenues.

Recent performance

Fiscal 2026 revenues were $1.79 billion, up 4% from fiscal 2025, with GAAP diluted EPS of $8.95 and record non-GAAP EPS of $10.35. Operating cash flow was a record $275.9 million, up from $97.6 million. Q4 2026 revenues declined 4% year-over-year to $484.1 million due to Middle East conflict-related delivery delays. Backlog reached approximately $1.9 billion as of June 30, 2026.

Strategy

Management emphasizes disciplined execution, cash generation, and growing backlog. They have refined debt, extended maturities, and repurchased shares, ending fiscal 2026 with $359.8 million in cash. The company is investing in operational improvements, particularly in Healthcare, and advancing product development. Expansion opportunities are focused on the large pipeline in Security and broad-based demand in Optoelectronics.

Risks

  • Delivery delays from geopolitical conflicts — Middle East conflicts shifted timing of planned deliveries, impacting Q4 2026 revenues, though orders remain in backlog.
  • Product liability from detection failures — If security systems fail to detect threats, the company could face significant product liability claims, possibly exceeding insurance coverage.
  • Government and trade policy changes — Changes in U.S. and foreign government spending, tariffs, and trade friction (e.g., U.S.-China) could adversely affect demand and operations.
  • Macroeconomic and supply chain pressure — Global inflation, interest rate policies, labor shortages, and supply chain disruptions could impact costs and execution.

Outlook

For fiscal 2027, management introduced revenue guidance of $1.875 billion to $1.930 billion and non-GAAP EPS guidance. They cite a substantial backlog, a significant opportunity pipeline, and recent program wins positioning the company for growth. The CEO expects continued strong performance across divisions despite ongoing delivery timing uncertainties.

Recent SEC filings

40 most recent
Annual, quarterly & current reports